Login / Signup

Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another.

Pierre CabantousSylvie DaliphardVictor Bobée
Published in: Clinical case reports (2020)
Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.
Keyphrases
  • case report
  • chronic kidney disease
  • early onset
  • uric acid
  • mass spectrometry
  • high resolution
  • iron deficiency